Previously, STIM1 knockdown reduced store-operated Ca2+ entry and decreased hypoxia-induced PASMC proliferation, suggesting that STIM1 significantly impacts hypoxic pulmonary arterial hypertension [102], and CaN/NFAT shows increased activity in pulmonary arterial hypertension. The gene discussed is STIM1; the disease is pulmonary arterial hypertension.